Skip to Main Content

++

INTRODUCTION

++

docusate (dok-yoo-sate)

docusate calcium

DC Softgels, Dioctocal, Pro-Cal-Sof, Sulfolax, Surfak

docusate sodium

Colace, Correctol Stool Softener Soft Gels, Diocto, Docu, Docusoft S, DOK, DOS Softgels, DOS, DOSS, DSS, Dulcolax Stool Softener, Ex-Lax Stool Softener, Fleet Sof-Lax, Modane Soft, Philliips Liqui-Gels, Regulax-SS, Regulex, Silace, Image not available.Soflax, Stool Softener, Therevac SB

Classification

Therapeutic: laxatives

Pharmacologic: stool softeners

++
Indications
++

PO: Prevention of constipation (in patients who should avoid straining, such as after MI or rectal surgery). Rectal: Used as enema to soften fecal impaction.

++
Action
++

Promotes incorporation of water into stool, resulting in softer fecal mass. May also promote electrolyte and water secretion into the colon. Therapeutic Effects: Softening and passage of stool.

++
Adverse Reactions/Side Effects
++

EENT: throat irritation. GI: mild cramps. Derm: rashes.

++

PHYSICAL THERAPY IMPLICATIONS

++
Examination and Evaluation
++

  • Monitor any rashes or other abnormal skin responses. Report excessive or prolonged skin reactions to the physician.

++
Interventions
++

  • Instruct patient how to breathe and avoid straining during bowel movements to prevent a Valsalva maneuver.

++
Patient/Client-Related Instruction
++

  • Advise patient to avoid overuse of laxatives. Encourage patient to use other forms of bowel regulation, such as increasing fiber and bulk in the diet, increasing fluid intake, and regular exercise.

  • Advise patient to report other troublesome side effects such as prolonged or severe throat irritation or abdominal cramps.

++
Pharmacokinetics
++

Absorption: Small amounts may be absorbed from the small intestine after oral administration. Absorption from the rectum is not known.

++

Distribution: Unknown.

++

Metabolism and Excretion: Amounts absorbed after oral administration are eliminated in bile.

++

Half-life: Unknown.

++

Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print

TIME/ACTION PROFILE (softening of stool)

ROUTE ONSET PEAK DURATION
PO 24–48 hr (up to 3–5 days) unknown unknown
Rectal 2–15 min unknown unknown

++
Contraindications/Precautions
++

Contraindicated in: Hypersensitivity; Abdominal pain, nausea, or vomiting, especially when associated with fever or other signs of an acute abdomen.

++

Use Cautiously in: Excessive or prolonged use may lead to dependence; Should not be used if prompt results are desired; OB/Lactation: Has been used safely.

++
Interactions
++

Drug-Drug: None significant.

++
Route/Dosage
++
Docusate Calcium
++

PO (Adults): 240 mg once daily.

++
Docusate Sodium
++

PO (Adults and Children >12 yr): 50–400 mg in 1–4 divided doses.

++

PO (Children 6–12 yr): 40–150 mg in 1–4 divided doses.

++

PO (Children 3–6 yr): 20–60 mg in 1–4 divided doses.

++

PO (Children <3 yr): 10–40 mg in ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.